Alcohol cancer risk message study
Part of Cancer clinical trials.
This study tests messages about alcohol and cancer risk. It might help you understand how drinking affects your health if you have certain cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or older
- You live in the United States
- You can read and speak English
- You have been diagnosed with cancer of the mouth, throat, voice box, liver, colon, rectum, or breast
- You have had at least 1 alcoholic drink in the past 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to explain the benefits and risks of new cancer drugs in a way that is easier to understand. It helps researchers learn how to communicate better with patients like you.
This study looks at how drinking alcohol affects young women's understanding of breast cancer risk. It involves answering questions and possibly wearing a sensor to track drinking.
This study looks at how a breakdown product from alcohol (acetaldehyde) may play a role in oral (mouth) cancer. It may help researchers understand who is more affected by alcohol and why.
This study tests different ways to help cancer patients address their alcohol use as part of their treatment. It aims to find the best approach to support patients in reducing or managing alcohol during cancer care.
This study compares two approaches for adults who drink regularly: advice on drinking in moderation vs. advice to stop drinking entirely. The goal is to see which approach better prevents major diseases and early death over time.
This study tests a program to help people who drink alcohol regularly cut back on high-risk drinking. The goal is to reduce cancer risk by changing drinking habits.
Hear when a new Alcohol trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.